Emerging Primary Care POC Diagnostics Market Trend 2025-2034: Advancements In Portable Point-Of-Care RT-PCR Solutions Help Enhancing Infectious Disease Diagnosis At The Point Of Care

How Is the Primary Care POC Diagnostics Market Projected to Grow, and What Is Its Market Size?
The market size of primary care point-of-care (POC) diagnostics has seen considerable growth in recent years. The market value is expected to increase from $16.46 billion in 2024 to $17.78 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. Factors such as the rising occurrence of chronic ailments, shift towards individualized treatment, escalating healthcare costs, enhanced regulatory frameworks with fast-track approval procedures, as well as greater focus on early identification and disease prevention methods, have fuelled growth during the historical period.

The market size for primary care POC (point-of-care) diagnostics is projected to experience robust growth in the coming years, escalating to $23.86 billion by 2029 with a compound annual growth rate (CAGR) of 7.6%. This expected growth over the forecast period can be associated with factors such as the rise of infectious disease outbreaks, the broadening scope in non-communicable diseases, the surge in utilization in home healthcare settings, the advancement in precision medicine initiatives, increasing investment in healthcare infrastructure, growth in disease prevalence, and the heightened awareness about the significance of early disease diagnosis. Some of the significant trends during the forecast period include incorporation of artificial intelligence (AI) and machine learning protocols, progress in molecular diagnostics technologies, compactness and mobility of POC diagnostic devices, integration with smart devices, and the application of multiplexing and panel testing in POC diagnostics.

What Is Stimulating Growth in the Primary Care POC Diagnostics Market?
The increase in infectious diseases is predicted to fuel the expansion of the primary care POC diagnostics market. Infectious diseases are conditions that occur due to pathogenic microorganisms like bacteria, viruses, fungi, or parasites and can spread from one person to another directly or indirectly via contact with infected surfaces, air, water, or vectors like insects. Factors such as adverse environmental conditions, urbanization, antimicrobial resistance, and insufficient vaccination coverage contribute to the prevalence of these diseases. Primary care POC diagnostics play a crucial role in fighting infectious diseases by enabling early detection, prompt treatment, and effective disease management in various healthcare environments. For example, a report released by the UK Health Security Agency in October 2023 showed a 22% increase in HIV diagnoses in England, from 3,118 in 2021 to 3,805 in 2022. Additionally, the World Health Organization (WHO) reported in November 2023 that approximately 10.6 million global cases of tuberculosis (TB) in 2022 impacted 5.8 million men, 3.5 million women, and 1.3 million children. Hence, the surge in infectious diseases is propelling the growth of the primary care POC diagnostics market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp

Who Are the Major Industry Players Fueling Primary Care POC Diagnostics Market Expansion?
Major companies operating in the primary care POC diagnostics market are Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd., Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc., DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

Which Key Developments Are Influencing the Primary Care POC Diagnostics Market?
Leading companies within the primary care POC diagnostics market are putting emphasis on embracing advanced technologies like portable point-of-care RT-PCR solutions to optimize their market revenue. Portable point-of-care (POC) RT-PCR are sleek, movable tools specifically engineered to execute real-time reverse transcription polymerase chain reaction (RT-PCR) tests minus the need for traditional laboratory surroundings. For instance, in October 2022, the India-established molecular diagnostic solution company, Genes2Me Pvt. Ltd., unveiled its Rapi-Q Point of Care RT PCR solution aimed at conditions such as HPV and tuberculosis. The easy-to-use solution, boasting an eight-well block pattern coupled with four fluorescent channels, is reputed to provide quicker results in under 45 minutes. The Rapi-Q system is both lightweight and portable, making it ideal for a range of settings including hospitals, blood banks, health centres, research laboratories and airports. It provides a high level of sensitivity, precision and overall performance in detecting a range of diseases, and can be used with over 50 lyophilized disease detection kits that are storeable at room temperature.

How Is the Segmentation of the Primary Care POC Diagnostics Market Defined?
The primary care POC diagnostics market covered in this report is segmented -

1) By Product: Glucose Monitoring, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products, Tumor Or Cancer Marker Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Other Products
2) By Prescription: Prescription Based, Over-The-Counter (OTC) Testing
3) By End-Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, Other End-Uses

Subsegments:
1) By Glucose Monitoring: Blood Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Test Strips For Glucose Meters, Glucose Control Solutions
2) By Cardiometabolic Testing Products: Blood Pressure Monitors, Lipid Profile Testing Kits, Hemoglobin A1c Testing Kits, Ecg Or Ecg Monitors, Hba1c Point-Of-Care Devices
3) By Infectious Disease Testing Products: Rapid Strep Tests, Influenza (Flu) Testing Kits, Covid-19 Rapid Tests, Hiv Rapid Testing Kits, Hepatitis Testing Kits, Malaria Rapid Diagnostic Tests (Rdts), Other Infectious Disease Tests
4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Testing Kits, Coagulation Control Solutions, Whole Blood Coagulation Monitors
5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based), Ovulation Prediction Kits, Pregnancy Test Strips, Fertility Monitoring Devices
6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits, Cea (Carcinoembryonic Antigen) Testing Kits, Ca-125 (Ovarian Cancer Marker) Kits, Her2 Testing Kits, Other Tumor Marker Test Kits
7) By Cholesterol Testing Products: Total Cholesterol Testing Kits, Ldl Or Hdl Testing Kits, Triglyceride Testing Kits, Point-Of-Care Lipid Panel Devices
8) By Hematology Testing Products: Hemoglobin Test Kits, Hematocrit Testing Kits, Complete Blood Count (Cbc) Kits, Point-Of-Care Hematology Analyzers, Hemoglobin A1c Testing Devices
9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests, Oral Fluid Drug Tests, Saliva-Based Drug Tests, Blood-Based Drug Tests, Breath Alcohol Tests
10) By Other Products: Allergy Testing Kits, Urinalysis Test Strips, Vitamin And Mineral Deficiency Testing Kits, Point-Of-Care Liver Function Tests, Kidney Function Testing Products, Blood Gas Testing Devices

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report

What Is the Leading Region in the Primary Care POC Diagnostics Market?
North America was the largest region in the primary care POC diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care POC diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Primary Care POC Diagnostics Global Market Report?

- Market Size Analysis: Analyze the Primary Care POC Diagnostics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Primary Care POC Diagnostics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Primary Care POC Diagnostics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Primary Care POC Diagnostics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15642

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.